A recent survey report by BioTrends Research Group* suggest that a majority of U.S. fibro patients currently taking a prescription medication for their symptoms don't feel the drugs help enough, and have “higher expectations.” Overall, more than two-thirds would be somewhat or very likely to switch to some new drug that offered improvement over their current therapy in treating pain, fatigue, and/or sleep, problems, says analyst Andrea Buurma. The data also suggest that patients now taking an FDA approved FM drug tend to be less “well-established” on their drugs than those on off-label drugs. Only 40% of those now taking one of the three approved drugs (Cymbalta, Lyrica, and Savella), and about 50% of those taking off-label drugs say they're “very unlikely” to ask their doctors if they can try a switch in the next 12 months. “This indicates there is a significant opportunity for emerging novel agents,” Buurma observes.
You can read more about how and why traditional medicine alone fails those with fibromyalgia by visiting the link below